Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial

Critical Care Medicine

Volumn 36, Issue 1, 2008, Pages 131-144

  Beale, Richard J ^a   Sherry, Tony ^a   Lei, Katie ^a   Campbell Stephen, Laura ^a   McCook, Julie ^a   Smith, John ^a   Venetz, Werner ^b   Alteheld, Birgit ^c   Stehle, Peter ^c   Schneider, Heinz ^d  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b Datagen AG   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

^d HealthEcon Ltd   (Switzerland)

Author keywords

Antioxidants; Early feeding; Enteral nutrition; Enteral pharmaconutrition; Glutamine; Immune modulation; Organ dysfunction; Sepsis; Sequential Organ Failure Assessment

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; BETA CAROTENE; DOPAMINE; FRESUBIN; GLUTAMINE; GLYCINE; INTESTAMIN; METHYLPREDNISOLONE; ORNITHINE; POTASSIUM; RECONVAN; SELENIUM; SERINE; SODIUM; TRACE ELEMENT; UNCLASSIFIED DRUG; VITAMIN; ZINC;

ADULT; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; ENTERIC FEEDING; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; NOSE FEEDING; NUTRIENT CONTENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 37549002889     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000297954.45251.A9     Document Type: Article

References (68)

1. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
2. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
3. Montejo JC, Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units: Enteral-nutrition-related gastrointestinal complications in critically ill patients: A multicenter study. Crit Care Med 1999; 27:1447-1453
4. Kudsk K: Enteral versus parenteral feeding in critical illness. In: From Nutritional Support to Pharmacological Nutrition in the ICU. Vol. 34. Pichard C, Kudsk K (Eds) Berlin, Springer, 2000, pp 115-124
5. Kong SE, Blennerhassett LR, Heel KA, et al: Ischaemia-reperfusion injury to the intestine. Aust N Z J Surg 1998; 68:554-561
6. Wilcox MH: Gastrointestinal disorders and the critically ill: Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterology 2003; 17:475-493
7. Lisbon A: Dopexamine, dobutamine, and dopamine increase splanchnic blood flow - What is the evidence. Chest 2003; 123:460S-463S
8. Putensen C, Wrigge H, Hering R: The effects of mechanical ventilation on the gut and abdomen. Curr Opin Crit Care 2006; 12:160-165
9. Taylor DE: Revving the motor of multiple organ dysfunction syndrome: Gut dysfunction in ARDS and multiorgan failure. Respir Care Clin N Am 1998; 4:611-631
10. Ali S, Roberts PR: Nutrients with immune-modulating effects: What role should they play in the intensive care unit? Curr Opin Anaesthesiol 2006; 19:132-9
11. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? JAMA 2001; 286:944-953
12. Suchner U, Heyland DK, Peter K: Immune-modulatory actions of arginine in the critically ill. Br J Nutr 2002; 87(Suppl 1):S121-S132
13. Bertolini G, Iapichino G, Radrizzani D, et al: Early enteral immunonutrition in patients with severe sepsis: Results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003; 29:834-840
14. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr 2006; 25:210-223
15. Vincent JL, de Mendoça A, Cantraine C, et al: Use of SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med 1998; 26:1793-1800
16. Moreno R, Vincent JL, Matos R, et al: The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care: Results of a prospective, multicentre study. Intensive Care Med 1999; 25:686-696
17. Janssens U, Graf C, Graf J, et al: Evaluation of the SOFA score: A single-center experience of a medical intensive care unit in 303 consecutive patients with predominantly cardiovascular disorders. Intensive Care Med 2000; 26:1037-1045
18. Mac Fie J: European round table: The use of immunonutrients in the critically ill. Clin Nutr 2004; 23:1426-1429
19. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
20. Fürst P, Pollack C, Graser T, et al: Appraisal of four pre-column derivatization methods for the high-performance liquid chromatography determination of free amino acids in biological materials. J Chromatogr 1990; 499:557-570
21. Erhard JG, Heinrich F, Biesalski HK: Determination of retinal, antioxidant vitamins and homocysteine in skin puncture blood. Int J Vitamin Nutr Res 1999; 69:309-314
22. Jentzsch AM, Bachmann H, Fürst P, et al: Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20:251-256
23. Kuhn KS, Krasselt AI, Fürst P: Glutathione and glutathione metabolites in small tissue samples and mucosal biopsies. Clin Chem 2000; 46:1003-1005
24. Artinian V, Krayem H, DiGiovine B: Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest 2006; 129:960-967
25. Adam S, Batson S: A study of problems associated with the delivery of enteral feed in critically ill patients in five ICUs in the UK. Intensive Care Med 1997; 23:261-266
26. Kieft H, Roos AN, van Drunen JD, et al: Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med 2005; 31:524-532
27. Pontes-Arruda A, Aragão AM, Albuquerque JD: Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34:2325-2333
28. Ziegler TR, Ogden LG, Singleton KD, et al: Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005; 31:1079-1086
29. Sato N, Moore FA, Kone BC, et al: Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol 2006; 290:G616-G623
30. Sato N, Moore FA, Smith MA, et al: Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma 2005; 58:455-461
31. De-Souza DA, Greene LJ: Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine. Crit Care Med 2005; 33:1125-1135
32. Dechelotte P, Hasselmann M, Cynober L, et al: L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006; 34:598-604
33. van den Berg A, van Elburg RM, Westerbeek EA, et al: Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: A randomized controlled trial. Am J Clin Nutr 2005; 81:1397-1404
34. Klek S, Kulig J, Szczepanik AM, et al: The clinical value of parenteral immunonutrition in surgical patients. Acta Chir Belg 2005; 105:175-179
35. Peng X, Yan H, You Z, et al: Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 2004; 30:135-139
36. Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A, et al: L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 2004; 23:13-21
37. Garrel D, Patenaude J, Nedelec B, et al: Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial. Crit Care Med 2003; 31:2444-2449
38. Furst P, Pogan K, Stehle P: Glutamine dipeptides in clinical nutrition. Nutrition 1997; 13:731-737
39. Canadian clinical practice guideline for nutrition support in the mechanically ventilated, critically ill adult patient. http://www. criticalcarenutrition.com/docs/cpg/4.1c_englu_07.pdf
40. Schulman AS, Willcutts KF, Claridge JA, et al: Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med 2005; 33:2501-2506
41. Schulman AS, Willcutts KF, Claridge JA, et al: Does enteral glutamine supplementation decrease infectious morbidity? Surg Infect (Larchmt) 2006; 7:29-35
42. Ochoa JB, Makarenkova V, Bansal V: A rational use of immune enhancing diets: When should we use dietary arginine supplementation? Nutr Clin Pract 2004; 19:216-225
43. Kozar RA, Verner-Cole E, Schultz SG, et al: The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma 2004; 57:1150-1156
44. Preiser JC, Peres-Bota D, Eisendrath P, et al: Gut mucosal and plasma concentrations of glutamine: A comparison between two enriched enteral feeding solutions in critically ill patients. Nutr J 2003; 2:13
45. Senkal M, Haaker R, Deska T, et al: Early enteral gut feeding with conditionally indispensable pharmaconutrients is metabolically safe and is well tolerated in postoperative cancer patients - A pilot study. Clin Nutr 2004; 23:1193-1198
46. Schroeder J, Alteheld B, Stehle P, et al: Safety and intestinal tolerance of high-dose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery. Eur J Clin Nutr 2005; 59:307-310
47. Heyland DK, Dhaliwalm R, Day A, et al: Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: A phase I dose-finding study. JPEN J Parenter Enteral Nutr 2007; 31:109-118
48. Schemmer P, Bradford BU, Rose ML, et al: Intravenous glycine improves survival in rat liver transplantation. Am J Physiol 1999; 23:G924-G932
49. Zhong Z, Enomoto N, Connor HD, et al: Glycine improves survival after hemorrhaging shock in the rat. Shock 1999; 12:54-62
50. Boelens PG, Houdijk AP, Fonk JC, et al: Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 2002; 132:2580-2586
51. Kyle U, Genton L, Heidegger CP, et al: Hospitalized mechanically ventilated patients are at higher risk of enteral underfeeding than non-ventilated patients. Clin Nutr 2006; 25:727-735
52. Motoyama T, Okamoto K, Kukita I, et al: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003; 31:1048-1052
53. Säemann MD, Bohmig GA, Zlabinger GJ: Short-chain fatty acids: Bacterial mediators of a balanced host-microbial relationship in the human gut. Wien Klin Wochenschr 2002; 114:289-300
54. Andoh A, Tsujikawa T, Fujiyama Y: Role of dietary fiber and short-chain fatty acids in the colon. Curr Pharm Des 2003; 9:347-358
55. Montejo JC: Enteral nutrition-related gastrointestinal complications in critically ill patients: A multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med 1999; 27:1447-1453
56. Robertson C, Goodman JC, Grossman RG, et al: Dietary nonprotein calories and cerebral infarction size in rats. Stroke 1992; 23:564-568
57. Snyderman SE, Morales S, Holt LE: The absorption of short chain fatty acids by premature infants. Arch Dis Child 1955; 30:83-84
58. Luiking YC, Poeze M, Dejong CH, et al: Sepsis: An arginine deficiency state? Crit Care Med 2004; 32:2135-2145
59. Houdijk APJ, Rijnsburger ER, Jansen J, et al: Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:772-776
60. Melis GC, Boelens PG, van der Sijp JR, et al: The feeding route (enteral or parenteral) affects the plasma response of the dipeptide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr 2005; 94:19-26
61. Heyland DK, Samis A: Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 2003; 29:669-671
62. Suchner U, Heyland DK, Peter K: Immune-modulatory actions of arginine in the critically ill. Br J Nutr 2002; 87(Suppl 1):S121-S132
63. Weimann A, Bastian L, Bischoff WE, et al: Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systematic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 1998; 14:165-172
64. Andrews FJ, Griffiths RD: Glutamine: Essential for immune nutrition in the critically ill. Br J Nutr 2002; 87(Suppl 1):S3-S8
65. Perry SE, Mostafa SM, Wenstone R, et al: Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med 2003; 29:1245-1252
66. Hynninen M, Pettila V, Takkunen O, et al: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 2003; 20:1-4
67. Ahlstrom A, Hynninen M, Tallgren M, et al: Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. Clin Nephrol 2004; 61:103-110
68. Van den Berghe G: Insulin therapy for the critically ill patient. Clin Cornerstone 2003; 5:56-63